Icon

BEVYXXA (nda208383)- (40MG,80MG)

BETRIXABAN PORTOLA PHARMS INC
40MG,80MG
No No
2031-Mar-29 2022-Jun-23
None None
None No
BEVYXXA is a factor Xa (FXa) inhibitor indicated for the prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE.
0 0 0
Total Other Developers 4
Drugs with Suitability No
40MG ** ** - - -
80MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.